MSB 2.29% $1.07 mesoblast limited

It will be a competitor who be against it.It is also all about...

  1. 429 Posts.
    lightbulb Created with Sketch. 71
    It will be a competitor who be against it.
    It is also all about lobbying the FDA when you have big pharmaceuticals interfering.

    Who knows, under Trumps repressive regime, he will just knock it back simply because he has a finger in a other pharmaceutical company.

    So while I am optimistic, the USA has lost it credibility as far as being an objective unbiased decision maker.

    Yes I am aware it is suppose to be I dependent and impartial but there is plenty of evidence that politicians and deep pocket companies influence the outcome rightly or wrongly.

    The other possibility is a delay in the decision sign off. They have only set a review date, but it could be weeks or months or years before you reach an outcome. Obviously everyone here and the patients wantit to be a quick, positive decision
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.025(2.29%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.10 $1.10 $1.06 $4.942M 4.613M

Buyers (Bids)

No. Vol. Price($)
6 70659 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 43531 2
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.